Synthesis and biological evaluation of geldanamycin analogs against human cancer cells

2015 ◽  
Vol 75 (4) ◽  
pp. 773-782 ◽  
Author(s):  
Yan-ping Li ◽  
Jin-jing Chen ◽  
Jia-jia Shen ◽  
Jing Cui ◽  
Lin-zhuan Wu ◽  
...  
RSC Advances ◽  
2021 ◽  
Vol 11 (30) ◽  
pp. 18333-18341
Author(s):  
Meng-Xue Wei ◽  
Jia-Ying Yu ◽  
Xin-Xin Liu ◽  
Xue-Qiang Li ◽  
Jin-Hui Yang ◽  
...  

Six novel artemisone–piperazine–tetronamide hybrids were efficiently synthesised and investigated for their cytotoxicity against some human cancer cells.


2017 ◽  
Vol 25 (2) ◽  
pp. 658-664 ◽  
Author(s):  
Chatchakorn Eurtivong ◽  
Victor Semenov ◽  
Marina Semenova ◽  
Leonid Konyushkin ◽  
Olga Atamanenko ◽  
...  

Molecules ◽  
2019 ◽  
Vol 25 (1) ◽  
pp. 158 ◽  
Author(s):  
Yan-Jiao Yin ◽  
Dan-Ling Huang ◽  
Bin Qiu ◽  
Dan Cai ◽  
Jiao-Jiao Zhang ◽  
...  

Five new meroterpenoids, zizhines P-S and U (1−4,7), together with two known meroterpenoids (5 and 6) were isolated from Ganoderma sinensis. Their structures including absolute configurations were assigned by using spectroscopic, computational, and chemical methods. Racemics zizhines P and Q were purified by HPLC on chiral phase. Biological evaluation found that 4, 5 and 6 are cytotoxic toward human cancer cells (A549, BGC-823, Kyse30) with IC50 values in the range of 63.43–80.83 μM towards A549, 59.2 ± 2.73 μM and 64.25 ± 0.37 μM towards BGC-823, 76.28 ± 1.93 μM and 85.42 ± 2.82 μM towards Kyse30.


2015 ◽  
Vol 11 ◽  
pp. 155-161 ◽  
Author(s):  
Manuel Johannes ◽  
Maximilian Reindl ◽  
Bastian Gerlitzki ◽  
Edgar Schmitt ◽  
Anja Hoffmann-Röder

The development of selective anticancer vaccines that provide enhanced protection against tumor recurrence and metastasis has been the subject of intense research in the scientific community. The tumor-associated glycoprotein MUC1 represents a well-established target for cancer immunotherapy and has been used for the construction of various synthetic vaccine candidates. However, many of these vaccine prototypes suffer from an inherent low immunogenicity and are susceptible to rapid in vivo degradation. To overcome these drawbacks, novel fluorinated MUC1 glycopeptide-BSA/TTox conjugate vaccines have been prepared. Immunization of mice with the 4’F-TF-MUC1-TTox conjugate resulted in strong immune responses overriding the natural tolerance against MUC1 and producing selective IgG antibodies that are cross-reactive with native MUC1 epitopes on MCF-7 human cancer cells.


2019 ◽  
Vol 97 (8) ◽  
pp. 603-614
Author(s):  
Maryam Nejati ◽  
Hossein Sadeghpour ◽  
Sara Ranjbar ◽  
Katayoun Javidnia ◽  
Najmeh Edraki ◽  
...  

Multi-drug resistance (MDR) in cancer cells is often associated with overexpression of P-glycoprotein (P-gp or ABCB1 or MDR1); therefore, modulators of this transporter might be helpful in overcoming MDR. In this study, 16 novel unsymmetrical dihydropyridine (DHP) derivatives bearing 2-pyridyl methyl carboxylate at C3 and a nitroimidazole or nitrophenyl ring at C4 positions of the DHP ring were synthesized. Their cytotoxicity was tested against four human cancer cells by MTT assay. The reversal capacity of MDR was examined in P-gp overexpressing cells (MES-SA/DX5) by measuring the alteration of doxorubicin’s IC50 and performing flow cytometric determination of intracellular rhodamine 123 accumulation. The calcium channel blocking (CCB) activity, as a side effect of DHPs, was tested on the ileum of a guinea pig. Molecular docking was performed to explain the binding mode of compounds. Two derivatives, 4a and 4c, containing 4-nitrophenyl at C4 and possessing methyl (4a) and iso-propyl (4c) carboxylates at the C5 position of DHP core demonstrated superior cytotoxic and MDR reversal activities and lower CCB effect. Docking analysis confirmed the importance of the 4-nitrophenyl ring for P-gp inhibitory activity. Some of the synthesized DHP derivatives with considerable MDR reversal capacity could be promising compounds for further discovery of useful agents for management of drug resistant cancer.


Molecules ◽  
2018 ◽  
Vol 23 (2) ◽  
pp. 310 ◽  
Author(s):  
Guanghui Ni ◽  
Yanling Tang ◽  
Minxin Li ◽  
Yuefeng He ◽  
Gaoxiong Rao

Planta Medica ◽  
2008 ◽  
Vol 74 (09) ◽  
Author(s):  
S Nam ◽  
R Buettner ◽  
X Liu ◽  
J Turkson ◽  
D Kim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document